IL17A and B-cell chronic lymphocytic leukemia: In CLL patients as well as in HV, the percentage of CD4+/CD3+/IL-17A+ (Th17) cells with intracellular IL-17A expression in non-activation assays was frequently lower than 1%, comparable with the level of autofluorescence.